Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 8, Issue 8, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-07-14
DOI
10.1093/ofid/ofab371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections
- (2020) Sara Alosaimy et al. Open Forum Infectious Diseases
- Real-world data: towards achieving the achievable in cancer care
- (2019) Christopher M. Booth et al. Nature Reviews Clinical Oncology
- Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other among Patients with Serious Infections due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
- (2019) Thomas Lodise et al. Open Forum Infectious Diseases
- Early experience with meropenem-vaborbactam for treatment of carbapenem-resistant Enterobacteriaceae infections
- (2019) Ryan K Shields et al. CLINICAL INFECTIOUS DISEASES
- Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
- (2019) Sarah C J Jorgensen et al. Open Forum Infectious Diseases
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection
- (2018) Keith S. Kaye et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae
- (2018) Sarah Christina Jane Jorgensen et al. PHARMACOTHERAPY
- Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?
- (2018) John H Powers et al. BMJ-British Medical Journal
- Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?
- (2018) John H Powers et al. BMJ-British Medical Journal
- Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study
- (2018) Jason C Gallagher et al. Open Forum Infectious Diseases
- Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials
- (2017) Elizabeth L. Alexander et al. Open Forum Infectious Diseases
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started